PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract abrogated TNFα-induced MMP1 expression in HaCaT keratinocytes [PMID:33449301] and increased AQP3 gene expression [PMID:28894278].
Topical administration of agerarin ameliorated atopic dermatitis-like skin lesions and restored filaggrin (FLG) expression in a mouse model [PMID:35696096].
Ethanolic extract and agerarin promote hair growth via MAPK/AP-1 axis-dependent upregulation of SCUBE3 in human dermal papilla cells [PMID:42074317].
Methanol extracts of leaves showed antibacterial activity, with the maximum zone of inhibition against Staphylococcus epidermidis [PMID:27350770].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36496475 (2022) — Larvicidal and repellent potential of Ageratum houstonianum against Culex pipiens. · Scientific reports
- 2.PMID: 33449301 (2021) — Inhibition of EGR-1-dependent MMP1 transcription by ethanol extract of Ageratum houstonianum in HaCaT keratinocytes. · Molecular biology reports
- 3.PMID: 11454357 (2001) — Pyrrolizidine alkaloids from Ageratum houstonianum Mill. · Phytochemistry
- 4.PMID: 28894278 (2017) — Agerarin, identified from Ageratum houstonianum, stimulates circadian CLOCK-mediated aquaporin-3 gene expression in HaCaT keratinocytes. · Scientific reports
- 5.PMID: 39115787 (2025) — UPLC-ESI MS/MS- and GC-MS-Based Altitudinal Variations in the Bioactive Potential of Mikania micrantha and Ageratum houstonianum.